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Deletion of the long arm of chromosome 6 (del(6q)) 
is more frequently described in lymphoid 
proliferations than in other hematological 
malignancies; del(6q) is observed in acute 
lymphoblastic leukemia (ALL), in chronic 
lymphocytic leukemia (CLL), in prolymphocytic 
leukemia and in non-Hodgkin lymphomas (NHL) 
(15% cases, sometimes associated with 
t(14;18)(q32;q21)); these deletions are mainly 
reported to be terminal, but also interstitial. 
 
del(6q) - Courtesy Diane H. Norback, Eric B. Johnson, Sara 
Morrison-Delap Cytogenetics at theWaisman Center; R- 
banding (right) – Editor. 
Clinics and pathology 
Disease 
Childhood B-cell acute lymphoblastic leukemia (B-
ALL) 
 
Phenotype/cell stem origin 
Lack of specificity for a particular 
immunophenotype. 
Epidemiology 
Found in 5-15% of patients after conventional 
cytogenetic analysis, in 30% after FISH analysis, in 
5 to 25% of cases in loss of heterozygosity studies. 
Prognosis 
Not significantly different from patients lacking a 
6q rearrangement. 
Disease 
Childhood T-cell acute lymphoblastic leukemia (T-
ALL) 
Epidemiology 
del(6q) is one of the most frequent cytogenetic 
aberration occurring in 10-20% of cases and often 
associated with 14q11 or del(9p) abnormalities. 
Prognosis 
Outcome similar to cases with normal diploid 
karyotypes. 
Disease 
Adult acute lymphoblastic leukemia 
Phenotype/cell stem origin 
T-cell phenotype found in 50% of cases (ALL). 
Epidemiology 
del(6q) in adult-ALL occur with a lower frequency 
(5%) than in children and is reported predominantly 
in young adult (15 to 40 years aged). 
Prognosis 
Patients with a 6q change tented to have longer 
event free survival (EFS) (median: 11 months; 3 
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years EFS: 47%) than did patients without 6q 
changes (median EFS: 7 month; 3 years EFS: 20%). 
Disease 
B-cell small lymphocytic lymphoma 
Epidemiology 
del(6)(q21q23) is the most common recurrent 
cytogenetic abnormality in this disease. 
Clinics 
In cases with del(6q), a morphological appearance 
of peripheral blood large prolymphocytes, a mature 
B-cell phenotype and a typical clinical course of 
other well-differentiated lymphocytic neoplams are 
described. 
Disease 
Atypical chronic lymphocytic leukemia 
Prognosis 
Complex karyotypes with +12, del(13)(q14), 
del(11q), del(6)(q21q23) and possible 4q or 10q 
anomalies are associated with a poor prognosis. 
Disease 
Multiple myeloma 
Phenotype/cell stem origin 
Multiple myeloma (MM) is a malignant plasma cell 
proliferation of mature differentiated B-cell. 
Epidemiology 
del (6q) in multiple myeloma represent 15% of 
cases of MM. 
Prognosis 
del(6q) are more frequent in the hypodiploid group 
of multiple myeloma, bearing a worse prognosis 
(med survival of 1.5 yr). 
Cytogenetics 
Cytogenetics morphological 
The frequency of the deletions is difficult to 
estimate by conventional cytogenetic analysis 
because small interstitial deletions are beyond the 
sensitivity of the technique; furthermore, many 
studies have reported conflicting data on the 
putative region of overlap and the number of region 
involved; the break occurs predominantly in 6q21, 
but 6q15 is also often described; overall, del(6q) 
cases encompassed the 6q21 band. 
in acute lymphoblastic leukemia (ALL), del(6q) is 
the sole anomaly in about 30% of cases, or 
associated with other structural abnormalities such 
as del(12p) (early pre-B ALL), del(9p) (B and T-
cell immunophenotype), specific aberrations, such 




Genes involved and 
proteins 
Note 
6q21 band loss suggests the presence of a recessive 
tumour suppressor gene whose absence might 
contribute to malignant transformation and 
development of both T and precursor B-ALLs; the 
lack of specificity for a particular 
immunophenotype may imply that the gene or 
genes affected by 6q abnormalities are broadly 
active in the multistep process of lymphoid 
leukemogenesis. 
Putative tumour suppressor gene(s) on chromosome 
arm 6q remains to be identified; to demonstrate this 
loss of heterozygosity of informative markers 
(LOH) was analysed using PCR amplification of 
polymorphic microsatellite sequences; using 
polymorphic markers located from the 6q14-15 to 
telomere, LOH was detected in 5 to 25% of 
childhood ALL cases. 
Regarding LOH results, two distinct regions were 
identified: 
- first region flanked by D6S283 and D6S302 loci 
at 6q21-22 
- second region flanked by D6S275 and D6S283 
loci at 6q21. 
Using LOH analysis on several cases, the authors 
demonstrated an identical 6q21-22 structure at 
diagnosis and at relapse, suggesting that 6q deletion 
may be an initial event in leukemogenesis and may 
occur less frequently during progression of the 
disease. 
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